Genetic variants associated with physiological and biochemical indicators: A multi-centre whole-exome sequencing study of Chinese healthy participants

Zhe Wang; Zhiyan Liu; Guangyan Mu; Qiufen Xie; Shuang Zhou; Zining Wang; Yimin Cui; Qian Xiang

doi:10.1002/ctm2.70300

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (4) : e70300 DOI: 10.1002/ctm2.70300

LETTER TO THE JOURNAL

Genetic variants associated with physiological and biochemical indicators: A multi-centre whole-exome sequencing study of Chinese healthy participants

Author information +

History +

PDF

Cite this article

Download citation ▾

Zhe Wang, Zhiyan Liu, Guangyan Mu, Qiufen Xie, Shuang Zhou, Zining Wang, Yimin Cui, Qian Xiang. Genetic variants associated with physiological and biochemical indicators: A multi-centre whole-exome sequencing study of Chinese healthy participants. Clinical and Translational Medicine, 2025, 15(4): e70300 DOI:10.1002/ctm2.70300

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Arpegård J, Viktorin A, Chang Z, de Faire U, Magnusson PK, Svensson P. Comparison of heritability of Cystatin C- and creatinine-based estimates of kidney function and their relation to heritability of cardiovascular disease. J Am Heart Assoc. 2015; 4(1): e001467.

[2]	Kim HK, Tantry US, Smith SC, et al. The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost. 2021; 121(4): 422-432.

[3]	Sorrentino V, Fouchier SW, Motazacker MM, et al. Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein. Eur Heart J. 2013; 34(17): 1292-1297.

[4]	Targher G. Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer-a narrative review. Clin Chem Lab Med. 2010; 48(2): 147-157.

[5]	Xiang Q, Liu Z, Mu G, et al. Effect of genetic polymorphism including NUP153 and SVEP1 on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy Chinese subjects. Clin Drug Investig. 2022; 42(5): 447-458.

[6]	Liu Z, Xie Q, Zhao X, et al. The pharmacogenetic variability associated with the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy Chinese subjects: a national multicenter exploratory study. Clin Ther. 2024; 46(4): 313-321.

[7]	Xie Q, Li Y, Liu Z, et al. SLC4A4, FRAS1, and SULT1A1 genetic variations associated with dabigatran metabolism in a healthy Chinese population. Front Genet. 2022; 13: 873031.

[8]	Mu G, Xie Q, Liu Z, et al. Identification of genetic biomarkers associated with pharmacokinetics and pharmacodynamics of apixaban in Chinese healthy volunteers. Expert Opin Drug Metab Toxicol. 2023; 19(1): 43-51.

[9]	Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010; 52(5): 1836-1846.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.